{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:34:23Z","timestamp":1784630063948,"version":"3.55.0"},"reference-count":29,"publisher":"Oceanside Publications Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2021,5,1]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold>Hereditary Angioedema (HAE) is a rare, autosomal dominant, life threatening disease, secondary to the deficiency of C1-inhibitor, dysfunction of C1-inhibitor or inadequate control of the contact pathway. Presentation includes recurrent swelling of the skin, upper airway and the abdomen. Trauma can precipitate attacks, which in the airway can lead to asphyxia. For this reason, short term prophylaxis (STP) may be indicated before medical, surgical and dental procedures. The goal of the manuscript is to review short term prophylaxis for children of all ages.<jats:bold>Methods:<\/jats:bold>We searched the following search words: children, pediatric, adolescent, plasma derived C1-inhibitor, recombinant C1-inhibitor, surgery, medical procedures, prophylaxis, dental, Hereditary Angioedema, tranexamic acid, androgens, fresh frozen plasma, short term prophylaxis, lanadelumab, subcutaneous C1-inhibitor in Google Scholar and in PubMed to develop our results.<jats:bold>Results:<\/jats:bold>STP should be discussed at every visit. Plans should be individualized based upon the procedure, therapies available and shared decision making with patient\/parent. For high risk procedures plasma derived C1-inhibitor should be used at 20 units\/kg just prior to the procedure. Alternative agents for STP include recombinant C1-inhibitor, fresh frozen plasma, androgens, or tranexamic acid. In all cases, with or without the use of STP, 2 doses of on-demand therapy should be available in case of an attack.<jats:bold>Conclusion:<\/jats:bold>Herein, we review the published data on STP for pediatric patients with HAE and discuss first-line options, and off label use of medications, as well as review the guidelines pertaining to short term prophylaxis.<\/jats:p>","DOI":"10.2500\/aap.2021.42.210006","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T10:11:09Z","timestamp":1620900669000},"page":"205-213","source":"Crossref","is-referenced-by-count":18,"title":["Short-term prophylaxis for children and adolescents with hereditary angioedema"],"prefix":"10.2500","volume":"42","author":[{"given":"Oyindamola","family":"Ajewole","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Penn State University, Hershey, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosopefoluwa","family":"Lanlokun","sequence":"additional","affiliation":[{"name":"Division of Allergy and Immunology, Department of Pediatrics, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevenson","family":"Dimanche","sequence":"additional","affiliation":[{"name":"Department of Medicine, Penn State University, Hershey, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Craig","sequence":"additional","affiliation":[{"name":"Section of Allergy, Asthma and Immunology, Department of Medicine and Pediatrics, Penn State University, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.12688\/f1000research.11320.1","article-title":"Pediatric hereditary angioedema: an update","volume":"6","author":"Sabharwal","year":"2017","journal-title":"F1000Res"},{"key":"B2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0009922815616886","article-title":"Pediatric hereditary angioedema: onset, diagnostic delay, and disease severity","volume":"55","author":"Christiansen","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"key":"B3","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1542\/peds.2006-3303","article-title":"Management of hereditary angioedema in pediatric patients","volume":"120","author":"Farkas","year":"2007","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/pai.12168","article-title":"Pediatric hereditary angioedema","volume":"25","author":"MacGinnitie","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Clinical practice. Hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","article-title":"Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency","volume":"130","author":"Bork","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2004.08.001","article-title":"Current and future therapy for hereditary angioedema","volume":"114","author":"Zuraw","year":"2005","journal-title":"Clin Immunol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1572-0241.2006.00492.x","article-title":"Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency","volume":"101","author":"Bork","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1710-1492-10-17","article-title":"The prophylactic use of C1 inhibitor in hereditary angioedema patients undergoing invasive surgical procedures: a retrospective study","volume":"10","author":"Gavigan","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/all.12186","article-title":"Risk of angioedema following invasive or surgical procedures in HAE type I and II \u2013 the natural history","volume":"68","author":"Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2013","journal-title":"Allergy"},{"key":"B11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tripleo.2011.02.034","article-title":"Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study","volume":"112","author":"Bork","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"B12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaip.2019.08.011","article-title":"Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema","volume":"8","author":"Valerieva","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/all.12032","article-title":"Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor \u2013 a long-term survey","volume":"67","author":"Farkas","year":"2012","journal-title":"Allergy"},{"key":"B14","article-title":"Hereditary angioedema: short-term prophylaxis before procedures or stress to prevent angioedema episodes","author":"Zuraw"},{"key":"B15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/MOP.0000000000000832","article-title":"Hereditary angioedema in children: a review and update","volume":"31","author":"Pancholy","year":"2019","journal-title":"Curr Opin Pediatr"},{"key":"B16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0278-2391(99)90280-X","article-title":"The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures","volume":"57","author":"Farkas","year":"1999","journal-title":"J Oral Maxillofac Surg"},{"key":"B17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/all.13001","article-title":"International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency","volume":"72","author":"Farkas","year":"2017","journal-title":"Allergy"},{"key":"B18","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/all.13384","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014the 2017 revision and update","volume":"73","author":"Maurer","year":"2018","journal-title":"Allergy"},{"key":"B19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00431-012-1726-4","article-title":"Hereditary angioedema (HAE) in children and adolescents\u2014a consensus on therapeutic strategies","volume":"171","author":"Wahn","year":"2012","journal-title":"Eur J Pediatr"},{"key":"B20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1081-1206(10)60886-1","article-title":"Fresh frozen plasma for the treatment of hereditary angioedema","volume":"98","author":"Prematta","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2500\/ar.2015.6.0112","article-title":"Perioperative management for patients with hereditary angioedema","volume":"6","author":"Williams","year":"2015","journal-title":"Allergy Rhinol (Providence)"},{"key":"B22","doi-asserted-by":"crossref","first-page":"e20160575","DOI":"10.1542\/peds.2016-0575","article-title":"Management of children with hereditary angioedema due to C1 inhibitor deficiency","volume":"138","author":"Frank","year":"2016","journal-title":"Pediatrics"},{"key":"B23","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jaip.2019.01.054","article-title":"Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks","volume":"7","author":"Craig","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13223-019-0376-8","article-title":"The International\/Canadian Hereditary Angioedema Guideline","volume":"15","author":"Betschel","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2217\/imt-2018-0197","article-title":"A review of kallikrein inhibitor lanadelumab in hereditary angioedema","volume":"11","author":"Hwang","year":"2019","journal-title":"Immunotherapy"},{"key":"B26","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2217\/imt-2019-0128","article-title":"Oral plasma kallikrein inhibitor BCX7353 for treatment of hereditary angioedema","volume":"11","author":"Hwang","year":"2019","journal-title":"Immunotherapy"},{"key":"B27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema","volume":"9","author":"Busse","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B28","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2500\/aap.2020.41.200042","article-title":"Hereditary angioedema: special considerations in children","volume":"41","author":"Johnston","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B29","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.2500\/aap.2020.41.200058","article-title":"Triggers and short-term prophylaxis in patients with hereditary angioedema","volume":"41","author":"Craig","year":"2020","journal-title":"Allergy Asthma Proc"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2021\/00000042\/00000003\/art00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T17:57:47Z","timestamp":1699034267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2021.42.210006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5,1]]}},"alternative-id":["1088-5412(20210501)42:3L.205;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2021.42.210006","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}